Introduction -- The U.S. blood supply system -- History of the controversy -- Product treatment -- Donor screening and deferral -- Regulations and recall -- Risk communication to physicians and patients -- Conclusions and recommendations -- Appendixes -- Tables and figures
Notes
"Committee to Study HIV Transmission through Blood and Blood Products, Division of Health Promotion and Disease Prevention, Institute of Medicine."